Menopausal hormone therapy and hypertension: minimizing risk.
暂无分享，去创建一个
[1] A. Fournier,et al. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort. , 2021, Menopause.
[2] J. Manson,et al. Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS) , 2021, Menopause.
[3] J. Manson,et al. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? , 2019, Menopause.
[4] J. Manson,et al. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials , 2018, Menopause.
[5] Susan R. Johnson,et al. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. , 1996, JAMA.